Changes in Oxygenation and Serological Markers in Acute Exacerbation of Interstitial Lung Disease Treated with Polymyxin B Hemoperfusion

Background: Polymyxin B direct hemoperfusion (PMX-DHP) has been tried in acute exacerbation of interstitial lung disease (AE-ILD) patients and has shown clinical benefit. In this study, we tried to investigate the change in oxygenation and serologic markers after PMX-DHP treatment in AE-ILD patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Song-I, Chung, Chaeuk, Park, Dongil, Kang, Da Hyun, Lee, Jeong Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105740/
https://www.ncbi.nlm.nih.gov/pubmed/35566611
http://dx.doi.org/10.3390/jcm11092485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105740/
https://www.ncbi.nlm.nih.gov/pubmed/35566611
http://dx.doi.org/10.3390/jcm11092485

Ejemplares similares